ArticleCancers2026

Molecular Subtype-Associated Response to Cyclophosphamide-Epirubicin-Cisplatin Regimen in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Retrospective Single-Center Study.

Wenbo Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.